NCT06434558

Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea

Enrolling by Invitation
Not specifiedAll AgesObservational
University of Pennsylvania
~10 participants
Updated 2025-10-31 on ClinicalTrials.gov
What's tested:Cryosa Procedure

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline in Oropharyngeal Fat at 6 Months
Measured over Baseline and 6 months
+1 more outcome measured
Obstructive Sleep Apnea of Adult
1 sites across 1 states
Pennsylvania1
  • Raj Dedhia, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Enrolled in the ARCTIC-3 clinical trial at the University of Pennsylvania\*
Provision of signed and dated informed consent form for ICE-OSA

Exclusion

MRI contraindications (claustrophobia, ferromagnetic implants/foreign bodies, etc.)
Patient is pregnant or becomes pregnant during their enrollment
  • Change from Baseline in Oropharyngeal Fat at 6 MonthsBaseline and 6 months

    Quantity of oropharyngeal fat will be measured with magnetic resonance imaging (MRI) before the Cryosa Procedure and 6 months after the Cryosa Procedure in all subject participants.

  • Change in Baseline Apnea Hypopnea Index at 6 MonthsBaseline and 6 Months

    All participants in this study, who are also enrolled in the ARCTIC-3 study, are undergoing a polysomnogram as part of the ARCTIC-3 study at baseline and at 6 months. AHI is measured during these sleep studies in every patient at both timepoints.